Pharmaceutical - Financial, USA

Filter

Current filters:

FinancialUSA

Popular Filters

1 to 25 of 56 results

US federal drug discount program “faces challenges as it expands”

US federal drug discount program “faces challenges as it expands”

12-08-2014

A federal program that provides billions in drug discounts to safety net hospitals and other health care…

FinancialHealthHealth Medical PharmaHealthcarePharmaceuticalPharmaceutical industryPharmacologyRANDRegulationUSA

Prosensa and CureDuchenne expand DMD collaboration with $7 million funding boost

Prosensa and CureDuchenne expand DMD collaboration with $7 million funding boost

12-08-2014

Dutch biotech company Prosensa will receive a 5 million euros ($7 million) funding boost from US non-profit…

Duchenne Muscular DystrophyFinancialNetherlandsPharmaceuticalProsensaRare diseasesResearchUSA

US court orders SIGA to pay PharmAthene lump sum expectation damages

US court orders SIGA to pay PharmAthene lump sum expectation damages

11-08-2014

USA-based biodefense company PharmAthene says that, on Friday, the Delaware Court of Chancery issued…

Anti-viralsDelaware Court of ChanceryFinancialLegalPharmaceuticalPharmAtheneSIGA TechnologiesTecovirimatUSA

Tufts CSDD says pharma collaborations to reduce development risk increasing

Tufts CSDD says pharma collaborations to reduce development risk increasing

08-08-2014

As pharmaceutical and biotech companies look to speed development, lower cost and reduce technical risks…

Business FinanceFinancialHealth Medical PharmaPharmaceuticalPharmaceutical industryPharmaceutical sciencesPharmacologyResearchUSA

Allergan attacks Valeant’s financial results

Allergan attacks Valeant’s financial results

06-08-2014

US Botox maker Allergan, the subject of a hostile $53 billion takeover attempt by Canada’s Valeant…

AllerganBusiness FinanceCanadaFinancialMergers & AcquisitionsPharmaceuticalUSAValeant PharmaceuticalsValeant Pharmaceuticals International

Biota tanks as flu drug candidate disappoints

Biota tanks as flu drug candidate disappoints

04-08-2014

USA-based Biota Pharmaceuticals saw its shares slump 29% to a record low of $2.29 on Friday, after the…

Anti-viralsAntibiotics and Infectious diseasesBiota PharmaceuticalsFinancialPharmaceuticalResearchUSA

US seniors save more than $11.5 billion on Rx drugs since 2010

US seniors save more than $11.5 billion on Rx drugs since 2010

31-07-2014

Information released by the US Department of Health and Human Services shows that more than 8.2 million…

FinancialHealthcareMedicarePharmaceuticalUSA

Merck's revenue drops 1% but still beats analysts' estimates for 2nd-qtr

Merck's revenue drops 1% but still beats analysts' estimates for 2nd-qtr

29-07-2014

Global revenue at pharma giant Merck & Co slipped 1% but the company has still exceeded analysts’ estimates…

FinancialFinancial accountingGardasilHepatitis CIsentressMerckMerck & CoNasonexPharma giantPharmaceuticalRemicadeUSAVytorinZetia

Earnings at Pfizer tank but still just beat expectations

Earnings at Pfizer tank but still just beat expectations

29-07-2014

Taking the brunt of generic competition to former blockbuster drugs, US pharma giant Pfizer posted a…

FinancialPfizerPharmaceuticalUSA

PhRMA comments on Medicare Rights Center paper

25-07-2014

“Finding viable solutions to contain Medicare costs is critically important, but imposing price controls…

FinancialHealthcarePharmaceuticalPricingUSA

Valeant takes Allergan's 'false and misleading statements' to Quebec and US financial regulators

Valeant takes Allergan's 'false and misleading statements' to Quebec and US financial regulators

22-07-2014

In the latest in an ongoing takeover attempt of Allergan by Valeant, Valeant has contacted financial…

AllerganBausch & LombCanadaFinancialPharmaceuticalRegulationUSAValeant Pharmaceuticals

Allergan reports strong 2nd-qtr figures but still plan to cut 1,500 jobs worldwide

Allergan reports strong 2nd-qtr figures but still plan to cut 1,500 jobs worldwide

21-07-2014

Botox maker Allergan has reported its second quarter operating results while also announcing that it…

AllerganAllerganBotoxFinancialPharmaceuticalUSA

Report: US state governments may spend $55 billion on hepatitis C drugs

Report: US state governments may spend $55 billion on hepatitis C drugs

17-07-2014

State legislatures in the USA will need to find billions in their budgets to purchase costly new hepatitis…

Anti-viralsExpress ScriptsFinancialGilead SciencesHealthcarePharmaceuticalSovaldiUSA

Baxter exceeds own predictions in 2nd-quarter

Baxter exceeds own predictions in 2nd-quarter

17-07-2014

US drugmaker Baxter International reported strong growth across its global franchises in the second quarter…

Baxter InternationalFinancialFundamental analysisPharmaceuticalUSAValuation

New products drive 2nd-qtr growth for Johnson & Johnson

New products drive 2nd-qtr growth for Johnson & Johnson

15-07-2014

Global health care products giant Johnson & Johnson, the first pharma to report second-quarter 2014 financial…

Business FinanceFinancialJohnson & JohnsonMonoclonal antibodiesPharmaceuticalPrednisoneUSA

Shire succumbs to AbbVie’s yet again increased offer of £53.20 per share

Shire succumbs to AbbVie’s yet again increased offer of £53.20 per share

14-07-2014

Ireland-headquartered Shire, which just on Friday confirmed it had finally entered talks with suitor…

AbbVieAdalimumabFinancialIrelandMergers & AcquisitionsPharmaceuticalShireUSA

PhRMA says too many patients can’t access vital medicines

PhRMA says too many patients can’t access vital medicines

30-06-2014

A recent discussion held by the Pharmaceutical Research and Manufacturers of America (PhRMA) has concluded…

FinancialPharmaceuticalUSA

AbbVie justifies its position regarding Shire offer

AbbVie justifies its position regarding Shire offer

26-06-2014

US drugmaker AbbVie has set out its ‘strategic rationale’ for its proposal to buy Ireland headquartered…

AbbVieFinancialPharmaceuticalShire PharmaceuticalsUSA

Modest uptick projected in US health care spending growth rate in 2015

25-06-2014

After a five-year contraction in employer health care spending growth, medical inflation in the USA is…

FinancialHealthcarePharmaceuticalUSA

AbbVie raises expectations driven by strong performance

AbbVie raises expectations driven by strong performance

24-06-2014

US drugmaker AbbVie has raised the midpoint of its full-year 2014 earnings-per-share guidance by six…

AbbVieAmortizationBusiness FinanceFinanceFinancialGuidancePharmaceuticalUSAUSD

GlaxoSmithKline in $105 million settlement for mis-selling with 44 US states

GlaxoSmithKline in $105 million settlement for mis-selling with 44 US states

05-06-2014

UK pharma giant GlaxoSmithKline has agreed to a $105 million settlement with 44 US states and the District…

AdvairFinancialGlaxoSmithKlineLegalMarkets & MarketingNeurologicalPaxilPharmaceuticalRespiratory and PulmonaryUSAWellbutrin

Avastin could save the USA $29 billion if used instead of Lucentis

Avastin could save the USA $29 billion if used instead of Lucentis

04-06-2014

Using Avastin (bevacizumab) from Swiss drug major Roche instead of Lucentis (ranibizumab) from fellow…

AvastinBevacizumabFinancialLucentisNovartisOphthalmicsPharmaceuticalRocheUSA

1 to 25 of 56 results

Company Spotlight

ImmunoGen

ImmunoGen

Back to top